Final results of a Spanish Lung Cancer Group (SLCG) phase II study of paclitaxel (PAC) plus gemcitabine (GEM) in locally advanced and metastatic non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Isla, D [1 ]
González-Larriba, JL [1 ]
Felip, E [1 ]
Camps, C [1 ]
Artal, A [1 ]
Carrato, A [1 ]
Azagra, P [1 ]
Alberola, V [1 ]
Massutti, B [1 ]
Rosell, R [1 ]
机构：
[1] Hosp Clin Lozano Blesa, Zaragoza, Spain
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
521P
引用
收藏
页码：114 / 114
页数：1
相关论文
共 50 条
  • [21] Gemcitabine and carboplatin in patients with locally advanced or metastatic non-small cell lung cancer: a prospective phase II study
    Kortsik, C
    Albrecht, P
    Elmer, A
    LUNG CANCER, 2003, 40 (01) : 85 - 90
  • [22] Phase II study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancer
    Boyer, MJ
    Mitchell, P
    Goldstein, D
    Millward, MJ
    Olver, IN
    Clarke, SJ
    Richardson, G
    Davis, I
    LUNG CANCER, 2001, 32 (01) : 89 - 94
  • [23] Gemcitabine-Oxaliplatin combination (GEM-OHP) in metastatic non-small cell lung cancer (NSCLC): Preliminary results of a phase II study
    Lippe, Paolo
    Mazzanti, Paola
    Recchia, Francesco
    Massacesi, Cristian
    Imperatori, Luca
    Cappelletti, Claudia
    Bonsignori, Maurizio
    Mattioli, Rodolfo
    ANNALS OF ONCOLOGY, 2004, 15 : 176 - 176
  • [24] A multicenter phase II study of induction chemotherapy with gemcitabine and carboplatin in locally advanced non-small cell lung cancer (NSCLC)
    Aerts, Joachim G.
    van Klaveren, Rob J.
    Surmont, Veerle
    Senan, Suresh
    Tan, Yoeke
    Vernhout, Rene
    van Wijhe, Gerda
    Verhoeven, Gert T.
    Hoogsteden, Henk C.
    van Meerbeeck, Jan P.
    ANNALS OF ONCOLOGY, 2004, 15 : 174 - 175
  • [25] XRCC3 codon 241 polymorphism is a predictive factor for survival to first-line oxaliplatin (Ox) plus paclitaxel (pac) in advanced non-small cell lung cancer (NSCLC): Spanish lung cancer group (SLCG) 0103 phase II trial
    Garrido, Pilar
    Isla, Dolores
    Gil, A.
    Lopez-Brea, Marta
    Lianes, Pilar
    Gonzalez-Larriba, Jose Luis
    Sanchez Ronco, Maria
    Luis Ramirez, Jose
    Gupta, Jalaj
    Taron, Miquel
    ANNALS OF ONCOLOGY, 2006, 17 : 257 - 258
  • [26] Cisplatin, gemcitabine, and paclitaxel in locally advanced or metastatic non-small-cell lung cancer: A phase I-II study
    Frasci, G
    Panza, N
    Cornella, P
    Nicolella, GP
    Natale, M
    Manzione, L
    Bilancia, D
    Cioffi, R
    Maiorino, L
    De Cataldis, G
    Belli, M
    Micillo, E
    Mascia, V
    Massidda, B
    Lorusso, V
    De Lena, M
    Carpagnano, F
    Contu, A
    Pusceddu, G
    Comella, G
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) : 2316 - 2325
  • [27] Paclitaxel/gemcitabine versus paclitaxel/vinorelbine in advanced non-small cell lung cancer (NSCLC): A phase III randomized study
    Kosmidis, P. A.
    Timotheadou, E.
    Koutras, A.
    Pentheroudakis, G.
    Christodoulou, C.
    Dimopoulos, A. M.
    Bafaloukos, D.
    Samantas, E.
    Pectasides, D.
    Syrigos, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [28] A phase II of gemcitabine in advanced non-small cell lung cancer
    Koynov, K
    Tzekova, V
    Mincheva, N
    Scherer, A
    Krejcy, K
    3RD INTERNATIONAL CONGRESS ON LUNG CANCER, 1998, : 231 - 234
  • [29] Phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
    Manegold, C.
    Digumarti, R.
    Zukin, M.
    de Marinis, F.
    Mellerngaard, A.
    Gandara, D.
    Simms, L.
    Kaiser, C.
    Blatter, J.
    Gatzemeier, U.
    EJC SUPPLEMENTS, 2007, 5 (06): : 9 - 9
  • [30] Phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
    Scagliotti, Giorgio
    Purvish, Parikh
    von Pawel, Joachim
    Biesma, Bonna
    Vansteenkiste, Johan
    Manegold, Christian
    Simms, Lorinda
    Posther, Sugarman Katherine
    Obasaju, Coleman
    Blatter, Johannes
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S306 - S306
12345